^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
SPOT-MAS 10 Test

Type:
Laboratory Developed Test
Related tests:
Evidence

News

22d
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions’ SPOT-MAS 10 Multi-Cancer Screening Test (Yahoo Finance)
''Gene Solutions...today announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to SPOT-MAS 10, its multi–omics blood test designed to detect cancer–associated signals.''
Clinical
|
SPOT-MAS 10 Test
7ms
SPOT-MAS Launches in Taiwan: AI-Powered Multi-Cancer Early Detection Ushers in a New Era of Precision Medicine (PRNewswire)
''Gene Solutions...Taiwan joins this movement with the introduction of SPOT-MAS – an advanced screening solution developed by Gene Solutions, a global leader in precision oncology and genomics, in collaboration with local partner Gene Health. ''
Launch • Clinical
|
SPOT-MAS 10 Test
1year
Gene Solutions Leads the Way in Cancer Early Detection with Asia’s First Clinical Validated Multi-Cancer Blood Test (PRNewswire)
"Gene Solutions...proudly announces a groundbreaking achievement in cancer early detection. The company's innovative SPOT-MAS test has become the first multi-cancer screening blood test in Asia to complete large prospective cohort validation, as published in BMC Medicine. This milestone marks a major advancement, enabling large-scale, non-invasive early detection."
Clinical
|
SPOT-MAS 10 Test